Immunization, Hib3 (% of children ages 12-23 months) in Iran
Iran: Immunization, Hib3 (% of children ages 12-23 months) was 98.0% in 2024. ▬ Flat
Immunization, Hib3 in Iran, 2015–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Iran is 98.0%, measured in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 1.0% on the previous year and unchanged over ten years.
Over the whole period, immunization, hib3 in Iran peaked at 99.0% in 2016 and was at its lowest, 98.0%, in 2015.
That places Iran 20th out of 191 countries with data for 2024, putting it in the top 10%.
Immunization, Hib3 (% of children ages 12-23 months) in Iran, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2015 | 98.0% | — |
| 2016 | 99.0% | +1.0% |
| 2017 | 99.0% | +0.0% |
| 2018 | 99.0% | +0.0% |
| 2019 | 99.0% | +0.0% |
| 2020 | 99.0% | +0.0% |
| 2021 | 98.0% | -1.0% |
| 2022 | 99.0% | +1.0% |
| 2023 | 99.0% | +0.0% |
| 2024 | 98.0% | -1.0% |
Iran compared with similar countries
- Iran's 98.0% is above the median for upper middle income countries, which is 91.0%, 1.1× the median. (57 countries reporting)
- Iran's 98.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 96.0%, 1.0× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 98.8% | 98.0% | 99.0% | 5 |
| 2020s | 98.6% | 98.0% | 99.0% | 5 |
Countries ranked near Iran
More health data for Iran
- Un projection of annual infant deaths, annual growth rate -1.38 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5627 % change on previous year (2090)
- Un projection of annual infant deaths 1,070 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.88 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0311 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0327 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Iran?
- Immunization, hib3 in Iran was 98.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Iran?
- The highest recorded value was 99.0% in 2016.
- What is the lowest immunization, hib3 recorded in Iran?
- The lowest recorded value was 98.0% in 2015.
- How does Iran rank for immunization, hib3?
- Iran ranks 20th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Iran?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Iran data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.